The pharmaceutical sector of Hong Kong stocks strengthened, and innovative pharmaceuticals and CXO leaders collectively boosted. As of press release, Medicinal Biotech and Medicinal Kangde have risen 9%, BeiGene Shenzhou has risen by about 8%, and Kangfang Biotech has risen by about 6%.

The pharmaceutical sector of Hong Kong stocks strengthened, and innovative pharmaceuticals and CXO leaders collectively boosted. As of press release, Medicinal Biotech and Medicinal Kangde have risen 9%, BeiGene Shenzhou has risen by about 8%, and Kangfang Biotech has risen by about 6%.